Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 44, 2009, Pages 18680-18685

  Rioux, John D ^a   Goyette, Philippe ^a   Vyse, Timothy J ^b   Hammarström, Lennart ^c   Fernando, Michelle M A ^b   Green, Todd ^d   De Jager, Philip L ^d,e   Foisy, Sylvain ^a   Wang, Joanne ^f   De Bakker, Paul I W ^g   Leslie, Stephen ^h   McVean, Gilean ^h   Padyukov, Leonid ^c   Alfredsson, Lars ^c   Annese, Vito ⁱ   Hafler, David A ^j   Pan Hammarström, Qiang ^c   Matell, Ritva ^k   Sawcer, Stephen J ^l   Compston, Alastair D ^l   Cree, Bruce A C ^f   Mirel, Daniel B ^d   Daly, Mark J ^e   Behrens, Tim W ^m   Klareskog, Lars ^k   Gregersen, Peter K ⁿ   Oksenberg, Jorge R ^f   Hauser, Stephen L ^f   more..

^a MONTREAL HEART INSTITUTE   (Canada)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^m GENENTECH INC   (United States)

ⁿ FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

more..

Author keywords

Autoimmunity; Genes; Genetics

Indexed keywords

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; GENE FREQUENCY; GENETIC VARIABILITY; GENOME ANALYSIS; HLA SYSTEM; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

EID: 73249122274     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0909307106     Document Type: Article

References (61)

1. Gorer PA (1936) The detection of a hereditary antigenic difference in the blood of mice by means of human group A serum. Journal of Genetics 32:17-31.
2. The MHC Consortium (1999) Complete sequence and gene map of a human major histocompatibility complex. Nature 401:921-923.
3. McDevittHO(2000) Discovering the role of the major histocompatibility complex in the immune response. Annu Rev Immunol 18:1-17.
4. Fernando MM, et al. (2008) Defining the role of the MHC in autoimmunity: A review and pooled analysis. PLoS Genetics 4:e1000024.
5. Khan MA,Mathieu A, Sorrentino R, Akkoc N (2007) The pathogenetic role of HLA-B27 and its subtypes. Autoimmunity Reviews 6:183-189.
6. Vader W, et al. (2003) The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 100:12390-12395.
7. Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205-1213.
8. Sawcer S, et al. (2002) A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain 125:1337-1347.
9. Aly TA, et al. (2006) Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci USA 103:14074-14079.
10. Harley JB, et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40:204-210.
11. Liu Y, et al. (2008) A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genetics 4:e1000041.
12. Klitz W, Stephens JC, Grote M, Carrington M (1995) Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region.AmJ Hum Genet 57:1436-1444.
13. Stenzel A, et al. (2004) Patterns of linkage disequilibrium in the MHC region on human chromosome 6p. Hum Genet 114:377-385.
14. Walsh EC, et al. (2003) An integrated haplotype map of the human major histocompatibility complex. Am J Hum Genet 73:580-590.
15. Miretti MM, et al. (2005) A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 76:634-646.
16. de Bakker PI, et al. (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 38:1166-1172.
17. Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of sevencommondiseases and 3,000 shared controls. Nature 447:661-678.
18. Leslie S, Donnelly P, McVean G (2008) A statistical method for predicting classical HLA alleles from SNP data. Am J Hum Genet 82:48-56.
19. FernandoMM,et al. (2007) Identification of 2 independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genetics 3:e192.
20. Fisher SA, et al. (2008) Genetic determinants of ulcerative colitis include theECM1locus and 5 loci implicated in Crohn's disease. Nat Genet 40:710-712.
21. Franke A, et al. (2008) Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 40:1319-1323.
22. Silverberg MS, et al. (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41:216-220.
23. Barrett JC, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40:955-962.
24. Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K (2000) Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease. Genes and Immunity 1:351-357.
25. Ding B, et al. (2009) Different patterns of associations with ACPA-positive and ACPA-negative rheumatoid arthritis in the extended MHC region. Arthritis Rheum 60:30-38.
26. Lee HS, et al. (2008) Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus. Molecular Medicine (Cambridge, Mass.)14:293-300.
27. Vorechovsky I, Webster AD, Plebani A, Hammarstrom L (1999) Genetic linkage of IgA deficiency to the major histocompatibility complex: Evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet 64:1096-1109.
28. Yeo TW, et al. (2007)Asecond major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol 61:228-236.
29. HomG, et al. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358:900-909.
30. Graham RR, et al. (2008) Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 40:1059-1061.
31. Tsao BP (2004) Update on human systemic lupus erythematosus genetics. Current Opinion in Rheumatology 16:513-521.
32. Yang Y, et al. (2007) Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): Low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 80:1037-1054.
33. Pickering MC, Walport MJ (2000) Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford) 39:133-141.
34. Satsangi J, et al. (1996) Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347:1212-1217.
35. Duerr RH, Barmada MM, Zhang L, Pfutzer R, Weeks DE (2000) High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet 66:1857-1862.
36. Rioux JD, et al. (2000) Genomewide search in Canadian families with inflammatory bowel disease reveals 2 novel susceptibility loci. Am J Hum Genet 66:1863-1870.
37. Arnett HA, et al. (2007) BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J Immunol 178:1523-1533.
38. Ahmad T, et al. (2003) The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens 62:527-535.
39. Mathew CG (2008) New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nature Reviews Genetics 9:9 -14.
40. Gregersen PK (2003) Teasing apart the complex genetics of human autoimmunity: Lessons from rheumatoid arthritis. Clinical Immunology 107:1-9.
41. Barcellos LF, et al. (2006) Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 15:2813-2824.
42. Janer M, et al. (1999) A susceptibility region for myasthenia gravis extending into the HLA- class I sector telomeric to HLA-C. Hum Immunol 60:909-917.
43. Vandiedonck C, et al. (2004) Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. Proc Natl Acad Sci USA 101:15464-15469.
44. Giraud M, et al. (2001) Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies. Neurology 57:1555-1560.
45. Cobain TJ, French MA, Christiansen FT, Dawkins RL (1983) Association of IgA deficiency with HLA A28 and B14. Tissue Antigens 22:151-154.
46. Hammarstrom L, et al. (1984) HLA antigens in selective IgA deficiency: Distribution in healthy donors and patients with recurrent respiratory tract infections. Tissue Antigens 24:35-39.
47. Sekine H, et al. (2007) Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci USA 104:7193-7198.
48. International Multiple Sclerosis Genetics Consortium (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357:851-862.
49. Lincoln MR, et al. (2005) A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 37:1108-1112.
50. Barcellos LF, et al. (2003) HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 72:710-716.
51. Babbe H, et al. (2000) Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192:393-404.
52. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, BruckW(2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123:1174-1183.
53. Galea I, et al. (2007) An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J Exp Med 204:2023-2030.
54. De Jager PL, et al. (2007) The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes and Immunity 8:387-397.
55. Klareskog L, et al. (2006)Anew model for an etiology of rheumatoid arthritis: Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54:38-46.
56. Plenge RM, et al. (2007) TRAF1-C5 as a risk locus for rheumatoid arthritis - a genome-wide study. N Engl J Med 357:1199-1209.
57. Tsinzerling N, Lefvert AK, Matell G, Pirskanen-Matell R (2007) Myasthenia gravis: A long term follow-up study of Swedish patients with specific reference to thymic histology. J Neurol Neurosurg Psychiatry 78:1109-1112.
58. Pan-Hammarstrom Q, et al. (2007) Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 39:429-430.
59. Hall IP, et al. (2006) Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: A genetic association study. Lancet 368:771-779.
60. Freedman ML, et al. (2004) Assessing the impact of population stratification on genetic association studies. Nat Genet 36:388-393.
61. de Bakker PI, et al. (2006) Transferability of tag SNPs in genetic association studies in multiple populations. Nat Genet 38:1298-1303.